Ketamine study for OCD
Part of Mental health clinical trials.
This study tests a form of ketamine called RR-HNK as a possible new treatment for OCD. It is for people who have not gotten enough relief from standard treatments or chose not to take them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with OCD.
- You have tried at least one standard OCD treatment (like medication or therapy) and it didn't work, or you chose not to take them.
- You agree to follow study rules, including fasting before the infusion and not joining other trials.
- You do not have an allergy to ketamine or any medical condition that would make the study unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests how ketamine may work quickly in people with obsessive-compulsive disorder (OCD), especially after at least one standard treatment didn’t help. If you join, you’ll need to follow study procedures like fasting before the experimental visit and not enrolling in other medication trials during the study.
This study tests whether ketamine can reduce obsessive-compulsive disorder (OCD) symptoms and how it affects stress and thinking. It also compares ketamine to usual care to see if benefits and side effects differ.
This trial looks at whether ketamine is safe and well-tolerated for certain mental health conditions when given in a hospital setting. It may help teams better understand side effects and comfort for people who may be offered ketamine.
This study tests whether a single dose of ketamine can help people with anorexia nervosa learn new ways of thinking about food and body image during recovery. You may be eligible if you are a teenager or young adult currently hospitalized for malnutrition.
This study tests a new experimental drug (2R,6R)-HNK, a chemical related to ketamine, given by IV infusion to see if it can help people with depression that hasn't improved with other treatments. The goal is to find a new option for people who have not found relief from standard antidepressants.
This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.
Hear when a new Obsessive-Compulsive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.